Pzena Investment Management LLC boosted its position in shares of Adient plc (NYSE:ADNT – Free Report) by 28.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,629,452 shares of the company’s stock after purchasing an additional 803,961 shares during the period. Pzena Investment Management LLC owned approximately 4.32% of Adient worth $62,535,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. BNP Paribas Financial Markets grew its holdings in Adient by 144.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 210,477 shares of the company’s stock valued at $4,750,000 after purchasing an additional 124,539 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in Adient by 202.8% during the 3rd quarter. Thrivent Financial for Lutherans now owns 69,831 shares of the company’s stock valued at $1,576,000 after purchasing an additional 46,766 shares in the last quarter. Principal Financial Group Inc. grew its holdings in Adient by 36.5% during the 3rd quarter. Principal Financial Group Inc. now owns 411,199 shares of the company’s stock valued at $9,281,000 after purchasing an additional 109,850 shares in the last quarter. Intech Investment Management LLC acquired a new stake in Adient during the 3rd quarter valued at $725,000. Finally, Citigroup Inc. grew its holdings in Adient by 30.2% during the 3rd quarter. Citigroup Inc. now owns 265,534 shares of the company’s stock valued at $5,993,000 after purchasing an additional 61,531 shares in the last quarter. 92.44% of the stock is owned by institutional investors and hedge funds.
Adient Trading Down 1.4 %
Adient stock opened at $14.73 on Tuesday. The firm’s 50-day moving average is $16.83 and its 200-day moving average is $19.23. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.86 and a current ratio of 1.08. Adient plc has a 1 year low of $13.64 and a 1 year high of $35.62. The company has a market cap of $1.24 billion, a P/E ratio of 736.25, a PEG ratio of 0.34 and a beta of 2.27.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Bank of America lowered shares of Adient from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $24.00 to $18.00 in a report on Tuesday, March 4th. Wells Fargo & Company lowered shares of Adient from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $27.00 to $20.00 in a report on Monday, December 16th. Barclays decreased their price objective on shares of Adient from $24.00 to $21.00 and set an “equal weight” rating for the company in a report on Wednesday, January 22nd. StockNews.com lowered shares of Adient from a “buy” rating to a “hold” rating in a report on Wednesday, March 5th. Finally, Morgan Stanley decreased their price objective on shares of Adient from $19.00 to $17.00 and set an “underweight” rating for the company in a report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating and eight have issued a hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $20.88.
Get Our Latest Analysis on ADNT
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Articles
- Five stocks we like better than Adient
- What is a Dividend King?
- How to Protect Your Portfolio When Inflation Is Rising
- How to Profit From Value Investing
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.